Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / KOD - Kodiak Sciences opens new Swiss facility to scale up manufacturing of lead drug candidate

KOD - Kodiak Sciences opens new Swiss facility to scale up manufacturing of lead drug candidate

Kodiak Sciences Inc
Kodiak Sciences (NASDAQ:KOD), which develops therapies for retinal diseases, and Swiss manufacturing company Lonza announced the opening of a new bioconjugation facility within Lonza's Visp, Switzerland manufacturing complex. The facility will support the scaled manufacturing of KOD's lead therapeutic candidate KSI-301. Once fully operational and if KSI-301 is approved for commercial use, the facility will have the capacity to supply over 10M dose equivalents of KSI-301 annually. KOD stock +10.5% to $6.63 in Thursday premarket trading. Up to Wednesday's close, the stock had lost nearly 93% YTD.

For further details see:

Kodiak Sciences opens new Swiss facility to scale up manufacturing of lead drug candidate
Stock Information
Company Name: Kodiak Sciences Inc
Stock Symbol: KOD
Market: NASDAQ
Website: kodiak.com
Menu
KOD KOD Quote KOD Short KOD News KOD Articles KOD Message Board
Get KOD Alerts

News, Short Squeeze, Breakout and More Instantly...